BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services Contract Manufacturing

PCI Pharma Services Acquires Ajinomoto Althea’s Altair to Build Global Powerhouse in Aseptic Filling and Advanced Drug Delivery

PCI Pharma Services ("PCI") is pleased to announce the launch of Ajinomoto Althea, the world's leading contract research and manufacturing organi...

May 05, 2025 | News

Lotte Biologics Seals First ADC Manufacturing Deal to Launch Full-Scale US Production

Lotte Biologics has announced the signing of its first official contract manufacturing agreement at its newly expanded antibody-drug conjugate (ADC) produc...

April 25, 2025 | News

Samsung Biologics Delivers KRW 1.3 Trillion Revenue in Q1 2025, Boosted by Plant 5 Launch and Expanding CDMO Contracts

Recorded Q1'25 consolidated revenue of KRW 1.3 trillion Recorded Q1'25 consolidated operating profit of KRW 486.7 billion Company expected to...

April 23, 2025 | News

WuXi Biologics Achieves Asia’s First Commercial PPQ Milestone with 3 x 5,000L Single-Use Bioreactors

- The campaign marks the successful commercial-scale PPQ completion of Asia's first 3 X 5,0...

April 21, 2025 | News

Porton Advanced Supports IND Approval of Tasly’s Dual-Targeting CAR-T Therapy for Recurrent Glioblastoma

Porton Advanced proudly announces its CDMO support for Tasly Pharmaceutical Co., Ltd.'s innovative CAR-T therapy, "P134 Cell Injection," which has received...

April 17, 2025 | News

Rege Nephro Acquires Tamibarotene Assets from Syros Pharmaceuticals to Advance ADPKD Program

Rege Nephro Co., Ltd. (Headquarter: Kyoto, Japan; Chief Executive Officer: Akifumi Morinaka) has announced that it has successfully acquired Tami...

April 16, 2025 | News

Shilpa Pharma’s Raichur Unit-2 in India Passes Second Straight FDA Inspection Without Observations

Shilpa Medicare announces that Shilpa Pharma Lifesciences – a wholly owned subsidiary – has successfully passed a U.S. Food and Drug Admin...

April 09, 2025 | News

AGC Biologics Sets New Benchmark in Japan With 5,000 L Single-Use Bioreactors at Yokohama CDMO Site

New CDMO site introducing the most advanced and large-scale single-use bioreactors in Japan AGC announced a strategic decision about the large-scale singl...

April 08, 2025 | News

TCI Biotech Elevates CDMO+ Services with US-Based Glass Bottling for Liquid Supplements

TCI Biotech (TCI Co., Ltd.), a CDMO+ organization specializing in health and wellness products, is spotlighting its comprehensive US-based glass bottling s...

April 03, 2025 | News

Langhua Pharmaceutical Receives FDA EIR Following Successful cGMP Inspection for the Fourth Time

Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ("Viva Biotech"), underwent a cGMP...

March 31, 2025 | News

Porton Advanced and Eureka Therapeutics Partner to Advance Next-Gen T-Cell Therapies

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleas...

March 20, 2025 | News

Celonic Integrates Merck’s Breez™ Micro-Bioreactor to Advance mAb Development

Celonic Group, a Swiss-Based Quality contract development and manufacturing organization (CDMO), has announced that it is integrating Merck’s Breez&t...

March 13, 2025 | News

Vetter to Double Cool Storage Capacity by 2028 with €150M Investment

Cool storage volume to be doubled by 2028 Third expansion stage of Vetter’s Center for Visual Inspection and Logistics State-of-the art, fully au...

March 11, 2025 | News

WuXi Biologics Introduces EffiX™ a High-Yield E. coli Expression Platform for Recombinant Proteins and Plasmid DNA Production

EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. ...

March 04, 2025 | News

Stay Connected